logo
Specialists call on farmers to monitor for blight in Ireland

Specialists call on farmers to monitor for blight in Ireland

Agriland31-05-2025
Potato growers attending a recent Teagasc farm walk in Co. Meath were told that monitoring for blight in Ireland must become a priority.
Recent years have seen multiple mutations taking hold within Europe's blight populations, resulting in the development of resistance to numerous blight fungicide chemistries.
Currently, the levels of blight population testing in Ireland is low relative to that taking place in the UK and across mainland Europe.
Teagasc plant disease specialist, Dr. Steven Kildea, commented: 'We need real time information on how blight populations are changing in Ireland. And the input of growers is critically important in making this happen.'
Monitoring for blight on-farm
Potato farmers can make suspected blight samples available to the agriculture and food development authority in one of two ways.
One is to physically put impacted leaves into an air-tight plastic bag and send them to Teagasc's Oak Park Crops Research Centre in Co. Carlow.
The other option is the use of Fast Technology for Analysis (FTA) cards. These have been given out to growers by Teagasc staff at recent potato events.
They allow growers to leave a sample of the blight-causing organism on the card. The cards are then submitted to Oak Park for analysis.
According to Dr. Kildea, real-time monitoring of blight populations is the only way that Irish potato growers can hope to keep on top of a disease that still has the potential to create havoc within Ireland's potato sector.
Fungicide availability is one issue when it comes to controlling blight. Using the chemicals effectively is the other challenge confronting growers.
So, ensuring that sprayers are fit for for purpose when used to apply blight fungicides is critically important.
The core objective is to ensure that crops are fully treated every time the sprayer goes into a field of potatoes.
Spraying potato crops requires total attention to detail
This means ensuring that all of the crops are sprayed with the correct rate of fungicide.
Growers should avoid misses, overlaps, double applications, and low application rates.
Put another way, growers should only sow what they can spray effectively. Global positioning satellite (GPS) systems can be used to deliver accurate boom overlaps.
Where headlands are concerned, accurate sprayer on-offs are vital. In addition, GPS switching needs to be set up correctly.
Distance from the boom, solenoid switching speed, and tractor forward speed all impact on this.
Corners should be reversed into, and curves in fields can also impact on application rates, especially with wider booms.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

The millionaire millennial seeking the presidency: How did Gareth Sheridan get so rich?
The millionaire millennial seeking the presidency: How did Gareth Sheridan get so rich?

The Journal

time44 minutes ago

  • The Journal

The millionaire millennial seeking the presidency: How did Gareth Sheridan get so rich?

BUSINESSMAN GARETH SHERIDAN is seeking to become the youngest-ever Irish presidential candidate during this year's election, and claims to have secured support to make that possible. Much of the Irish public were introduced to 35-year-old Sheridan for the first time this week as a millionaire, pharmaceutical tycoon who recently returned to Ireland having spent the last seven years building up his company in the US. But how, exactly, did he earn his millions? And what does his company do? Acquisitions and mergers Nurtiband, a US-based healthcare-led company valued at approximately $80m, was started by Sheridan in 2012, during his final year at DIT in Dublin, where he was studying businesses and management. Taking inspiration from a transdermal patch his father had for a heart condition, Sheridan wrote his undergraduate thesis on providing properly-dosed medicine to patients through more accessible means, like patches, which are less likely to abuse. Early social media posts from Sheridan show that the company began by selling supplements, such as energy and metabolism-boosting patches, but the Dubliner wanted to branch out into the opioid market. Former Áras contender Seán Gallagher was later enlisted as the company's President (he has since left and has no current relationship with Sheridan) as the CEO worked towards getting the company listed on the Nasdaq stock exchange. Nutriband's strategy focused on carrying out a number of mergers and acquisitions, purchasing companies through its own stock options as a private company, over the last ten years, Sheridan explained on The Entrepreneur Experiment podcast in April. Sheridan focused on merging with firms with existing specialities in pharmaceuticals and biotechnology. It listed on the New York-based stock exchanged in October 2023, generating over $6m on its first day. Nutriband has now focused wholly on opioids through transdermal patches – similar to products used for nicotine-replacement therapy. Opioids, a type of pain-relief medication, have proven to be addictive among some patients. While they are an effective method to treat chronic pain, doctors – particularly in the US – have been reluctant to prescribe the medicines. Image posted by Sheridan in 2023 after his company was listed on the Nasdaq stock exchange in New York. Gareth Sheridan Gareth Sheridan As a result, more people have sought to purchase opioids illegally, and the black market drugs trade responded by introducing potent or synthetic alternatives over the last decade. The most-famous of these in the US is fentanyl, currently. Sheridan said that the most-important of Nutriband's acquisitions was the purchase of 4P Therapeutics in 2018, a company from two pharma veterans who created AVERSA technology , which prevents the misuse of opioids. It is today his lead product. During one acquisition, Nutriband pulled out of purchasing the manufacturer of transdermal patches . It was subsequently reported that a lawyer representing the firm did not disclose their ownership position in both companies. Asked about this on RTÉ Radio One yesterday, Sheridan explained that it was the only time that his firm had faced any trouble with US authorities and that, for Nutriband, it was seen as a minor issue and required the firm to correct submitted paperwork. Advertisement Unique selling point Sheridan has said he wants Nutriband to benefit those who are ill, developing patches that provide patients with a safe dose of medicines that are commonly abused – primarily opioids – targeting those who are in need of the controversial medicines. If abused, the drugs can cause long-term health complications, impact organ health and – in the case of synthetic and potent alternatives especially – minor doses can result in death. We're up and running! Excited to have announced my intention to seek a nomination for the upcoming Presidential election. I look forward to setting out my values and vision for the Presidency over the coming days and continuing to engage with Councillors across the country. — Gareth Sheridan (@GPSheridan1) August 11, 2025 Sheridan's business case is that there are still many people, in the US particularly, who need these pain medicines for proper health-related reasons. He believes the managed doses from his firm's patches is a unique selling point and a prevention of abuse and addiction. He said that there's been an increase of American patients being told to use over-the-counter pain medication for illnesses, and claims his patches could be a safer and more appropriate option. Pharmaceutical patches Sheridan in April said acquisitions and mergers were 'the strategy' for the company. Some of the previous owners from the purchased companies went on to join Sheridan and held positions at Nutriband for a short time. He explained, due to his own lack of expertise in pharmacology, he needed those who could help actually develop his ideas. He added: 'It also kept us away from expensive money. I am able to retain today a good proportion of the company because we didn't do angel [investor] rounds, seed rounds. We didn't do the traditional route.' News reports of the company's activities recently have focused on its newest patch, which would deliver a proper prescribed dose of fentanyl . The firm is still in ongoing discussions with the US's drugs regulator, the Food and Drug Administration. In preparation for its approval, it has offered shareholders particular stock options to raise funds. Success? Nutriband is yet to generate any revenue. In its most-recent public quarterly report, at the end of October last year, it recorded a net-loss of $1.3m. Speaking to The Entrepreneur Experiment in April, Sheridan said: 'In most public companies it's either one person makes a million dollars or, years later, dozens of people make multiple millions of dollars. So there's patience and trust involved.' The Áras hopeful, who has stepped back as CEO from Nutriband to pursuit the election later this year, said he is certain the company will be worth a billion dollars in the future. Sheridan said the firm has been careful not to waste any funding too: 'We've been very careful not to raise money that we don't need – money that is sitting in a bank account at the expense of shareholders [...] It's just little things like that.' He told RTÉ Radio One yesterday that he believes Nutriband will still achieve that goal, with or without him. He said that he intends to have a stake in the firm, should he be placed on the ballot and elected President. Sheridan said he is seeking to be nominated as a candidate to represent the interests of young people who feel that they must emigrate for work and other opportunities due to the housing situation here. He is due to announced his platform's values later this week. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal

Scientists warn of dangers of 'new approach' to setting climate targets
Scientists warn of dangers of 'new approach' to setting climate targets

Agriland

time5 hours ago

  • Agriland

Scientists warn of dangers of 'new approach' to setting climate targets

A new study led by University of Galway has found that proposed Irish climate targets "protect methane emission privileges at the expense of poorer nations' development". The transition to a sustainable and equitable food system is "being undermined by a new approach to climate target setting" by livestock-exporting countries such as Ireland and New Zealand, the international study by climate scientists has warned. The study, led by University of Galway in partnership with the University of Melbourne, University College Cork and Climate Resource, has been published in the journal Environmental Research Letters. The scientists have called out the new 'temperature neutrality', also known as "no additional warming", which allows Ireland to maintain a high share of global agricultural methane emissions while claiming to meet its climate targets. This approach "dramatically reduces the level of ambition needed for overall greenhouse gas emission reduction", according to the research. The resulting targets have been proposed to the Irish government by the Climate Change Advisory Council, in part to reduce potential disruption from Ireland's legal commitment to achieve national climate neutrality by 2050, the scientists said. Temperature neutrality is a concept based on stabilising a country's contribution to global warming, rather than aiming for the more ambitious, established target of net-zero greenhouse gas emissions, the scientists said. In effect, temperature neutrality requires modest reductions in methane emissions from high-emitting countries, denying methane emission 'rights' to countries with low methane emissions. "As methane emissions are strongly linked with agricultural production, widespread adoption of temperature neutrality would lock-in current inequalities in the global food system, by reducing the need to curtail or offset methane emissions in current livestock-exporting countries such as Ireland," according to the study. The study shows that such exports "overwhelmingly go to other wealthy, food-secure countries". "Meanwhile, temperature neutrality severely restricts the development space for agriculture in low-income, food-insecure countries where livestock products are most needed to improve nutrition," according to the research. "Furthermore, the temperature neutrality approach underestimates the level of emissions offsetting required in livestock-exporting countries, delaying the development of new markets for farmers in those countries to deliver solutions to the climate and biodiversity crises." Lead scientist, Dr. Colm Duffy, honorary lecturer in agri-sustainability, School of Biological and Chemical Sciences and Ryan Institute, University of Galway, said that if every country adopted a temperature neutrality target, "we'd seriously jeopardise the Paris Agreement's goal of limiting warming to 1.5°C, or even 2°C". 'Worse still, this approach doesn't just weaken climate ambition, it entrenches inequality," he said. "It protects the status quo for wealthy countries while placing an unfair burden on poorer, food-insecure countries, limiting their ability to grow their own food systems.' The international research team ran a number of scenarios to assess the impact of the policy - which has also been proposed in New Zealand - on global mean temperatures. Apart from 'business as usual', the temperature neutrality approach performed the worst in terms of global warming emissions, the research found. By 2050, Ireland's per capita methane emissions would remain almost six times the global average. Dr. Duffy added: 'The science shows that the new policy essentially grandfathers methane emissions - meaning a country's future share of warming is based not on equity or ambition, but on historical share of emissions." Hannah Daly, professor in sustainable energy at University College Cork, said that for a country like Ireland with outsized methane emissions, "to base our long-term climate target on simply stabilising warming is inadequate to meet our global obligations and sets a dangerous precedent". David Styles, associate professor in agri-sustainability, School of Biological and Chemical Sciences and Ryan Institute, University of Galway, said: 'Ireland's agricultural sector has huge potential to contribute towards a future climate-neutral and biodiverse economy, but this requires big changes over time. "Establishing a robust and internationally defendable climate target is vital to plan for a just transition, not just internationally, but for Ireland's farmers. "Temperature neutrality falls short.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store